You just read:

Neurelis Announces That Intravail® Licensee, ARS Pharmaceuticals' Intranasal Epinephrine Product, Demonstrates Bioequivalent Exposure To Epinephrine Injectors

News provided by

Neurelis, Inc.

May 04, 2020, 09:00 ET